AXMP AXM Pharma Inc. featured news, full reports, and detailed charts
AXM Pharma Inc. (AXMP/AXMP.PK) Wrap Up:
AXM Pharma, Inc. engages in the manufacture, marketing, and distribution of over-the-counter and prescription pharmaceutical and neutraceutical products primarily in the People’s Republic of China. Its products include Asarone, an antiseptic, anti-inflammatory, asthma reducing, and cough prevention tablet; Elegance, a menstrual relief lotion; LiveComf, a compound sulfur cream used to alleviate dermatitis, seborrheica, scabies, acne, and eczema; Bodyward, a tablet to treat allergy caused by penicillin; Reheal, a capsule used to treat reduced memory capacity and impairment of cerebral function caused by acute/chronic cerebrovascular disease, cerebral trauma, and toxic cerebral disease; and Lif...AXM Pharma Inc. (AXMP:OTC)
|
Market Cap
896.2K
|
Total Revenue
2.0M
|
|
|
EBITDA
9.4M
|
DILUTED EPS TTM
-0.60
|
|
|
P/E
--
|
P/S
0.4x
|
|
|
Return On Asset
-52.39
|
Return On Equity
-492.06
|
|
| K = Thousands M = Millions B = Billions | ||
AXMP Top Compensated Officers
Executives, Board Directors
Key developments for AXM Pharma Inc. (AXMP)
On July 6, 2009, Mr. Baozhong Zhang resigned from his position as a director of AXM Pharma Inc. Mr. Zhang advised the Company that he was resigning for personal reasons. He did not note any disagreement with the Company concerning any matter relating to the Company's operations, policies or practices as a reason for his resignation.
AXM Pharma, Inc. filed its form 10K with the Securities and Exchange Commission. The company stated: “We are in urgent need of additional capital. Our cash resources have been depleted. We have not paid our employees in China since January 2006.” The company added: “We are currently in discussions with several funding sources in China to obtain financing to support operations going forward, but to date none of these discussions have resulted in additional financing. If we are unable to raise additional capital in the immediate future, we may be forced to cease business operations.”
AXMP Competitors
| Company | Last | Change | |
| No competitor information is available for AXMP. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | AXMP | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.4x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
AXMP |
||
AXMP transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||